Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Resistant Hypertension Variants Link to Hyperaldosteronism and Potassium Levels.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 09, 2026
Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial.
Journal: Journal of the American Heart Association
Published: May 14, 2026
Concussion AF trial: Longitudinal assessment of brain injury biomarkers and cognitive decline in elderly patients with atrial fibrillation.
Journal: Heart rhythm
Published: April 21, 2026
Examining covariate-specific treatment effects in individual participant data meta-analysis: Framing aggregation bias in terms of trial-level confounding and funnel plots.
Journal: Research synthesis methods
Published: February 02, 2026
Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 06, 2026
Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.
Journal: European heart journal
Published: December 22, 2025
CorCal Outcomes: A randomized trial using the pooled cohort equation or coronary artery calcium to select statin therapy in primary prevention patients. Study design and baseline characteristics.
Journal: American heart journal
Published: October 13, 2025
The genetic architecture of fibromyalgia across 2.5 million individuals.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
The genetic architecture of fibromyalgia across 2.5 million individuals.
Journal: Nature medicine
Published: September 18, 2025
Does Sex or Age Impact the Prognostic Value of a Zero Coronary Artery Calcium Score?
Journal: Journal of clinical medicine
Published: July 18, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibition.
Journal: Human molecular genetics
Published: March 10, 2025
Last Updated: 09/26/2026